US EditionGlass Pharms Signs Supply Deal with Mamedica in 'Milestone for UK Cultivation' - Business of Cannabis
Summary by Business of Cannabis
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Glass Pharms Signs Supply Deal with Mamedica in 'Milestone for UK Cultivation' - Business of Cannabis
Glass Pharms, the UK-based licensed cultivator of medical cannabis, has announced a new partnership with Mamedica, one of the country’s leading private medical cannabis clinics. Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use). Glass Pharms currently…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
